Veterinary Point Of Care Diagnostics Market (By Animal Type: Companion Animals, Livestock Animals; By Product: Consumables, Reagents, & Kits, Instruments & Devices; By Sample Type: Blood/Plasma/Serum, Urine, Fecal; By Testing: Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology; By Indication: Infectious Disease, General Ailments; By End-use: Veterinary Hospitals & Clinics, Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Point Of Care Diagnostics Market, By Animal Type

7.1.  Veterinary Point Of Care Diagnostics Market, by Animal Type, 2021-2030

7.1.1.    Companion Animals

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Livestock Animals

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Veterinary Point Of Care Diagnostics Market, By Product

8.1.  Veterinary Point Of Care Diagnostics Market, by Product, 2021-2030

8.1.1.    Consumables, Reagents, & Kits

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Instruments & Devices

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Veterinary Point Of Care Diagnostics Market, By Sample Type

9.1.  Veterinary Point Of Care Diagnostics Market, by Sample Type, 2021-2030

9.1.1.    Blood/Plasma/Serum

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Urine

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Veterinary Point Of Care Diagnostics Market, By Testing Category

10.1.        Veterinary Point Of Care Diagnostics Market, by Testing Category, 2021-2030

10.1.1.  Hematology

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Diagnostic Imaging

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Bacteriology

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Virology

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Cytology

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Virology

10.1.6.1.      Market Revenue and Forecast (2017-2030)

10.1.7.  Clinical Chemistry

10.1.7.1.      Market Revenue and Forecast (2017-2030)

10.1.8.  Parasitology

10.1.8.1.      Market Revenue and Forecast (2017-2030)

10.1.9.  Serology

10.1.9.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Veterinary Point Of Care Diagnostics Market, By Indication

11.1.        Veterinary Point Of Care Diagnostics Market, by Indication, 2021-2030

11.1.1.  Infectious Disease

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  General Ailments

11.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Veterinary Point Of Care Diagnostics Market, By End-use

12.1.        Veterinary Point Of Care Diagnostics Market, by End-use, 2021-2030

12.1.1.  Veterinary Hospitals & Clinics

12.1.1.1.      Market Revenue and Forecast (2017-2030)

12.1.2.  Home Care Settings

12.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 13.      Global Veterinary Point Of Care Diagnostics  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.2.  Market Revenue and Forecast, by Product (2017-2030)

13.1.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.1.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.1.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.1.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.1.8.  Rest of North America

13.1.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.1.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.1.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.        Europe

13.2.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.2.  Market Revenue and Forecast, by Product (2017-2030)

13.2.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.2.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.2.7.  UK

13.2.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.8.  Germany

13.2.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.9.  France

13.2.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.10.               Rest of Europe

13.2.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.2.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.2.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.2.  Market Revenue and Forecast, by Product (2017-2030)

13.3.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.3.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.8.  China

13.3.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.9.  Japan

13.3.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.10.               Rest of APAC

13.3.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.3.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.2.  Market Revenue and Forecast, by Product (2017-2030)

13.4.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.4.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.8.  North Africa

13.4.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.9.  South Africa

13.4.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.10.               Rest of MEA

13.4.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.4.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.2.  Market Revenue and Forecast, by Product (2017-2030)

13.5.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.5.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.5.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.5.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.5.8.  Rest of LATAM

13.5.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.5.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 14.  Company Profiles

14.1.              IDEXX Laboratories

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              Zoetis

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Virbac

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              Heska Corporation

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              Thermo Fisher Scientific, Inc.

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              Neogen Corporation

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              Mindray

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Esaote SpA

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              FUJIFILM Corporation

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           Woodley Equipment Company Ltd.

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

16.2.              Glossary of Terms